NCT01851369 2024-05-08TRC102 and Temozolomide for Relapsed Solid Tumors and LymphomasNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed93 enrolled 27 charts
NCT02770378 2021-10-05A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent GlioblastomaUniversity of UlmPhase 1/2 Completed10 enrolled